Phase-3 trials of Covid vaccine deferred for a fortnight in Lucknow hospital

Lucknow: The phase 3 trials of indigenously developed coronavirus vaccine Covaxin slated to commence from mid-October has been deferred by almost 15 days at Sanjay Gandhi Post Graduate Institute of Medical Sciences here.
Earlier the vaccine trials were scheduled to begin from October 15 at SGPGI and BRD Medical College, Gorakhpur including some other places in the country.
“The results of phase 2 trials of Covaxin are still being evaluated by the Drugs Controller General of India and hence now the next phase trials are expected to start in the last week of October 2020. The Covaxin is the first indigenously developed coronavirus vaccine and the phase 1 and 2 trials were conducted by Bharat Biotech and National Institute of Virology at 12 centres across the country,” SGPGI Director, Professor Radha Krishan Dhiman said here on Wednesday.
The phase 3 trials of the vaccine hold importance as it will give a final verdict before giving a green signal for the production of the vaccine. So far, the first two phases of the Covaxin have shown promising results.
Meanwhile, the number of active patients in UP was decreasing for the past 24 days and it was almost 44 per cent decrease after recording peak on September 17.